Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1143 result(s) found, displaying 526 to 550

  • AusPAR: Fosfomycin trometamol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Fosfomycin trometamol

  • AusPAR: Pegaspargase

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for pegaspargase

  • AusPAR: Leuprorelin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Leuprorelin

  • AusPAR: Etanercept

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Etanercept

  • AusPAR: Nadroparin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nadroparin

  • AusPAR: Atezolizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Atezolizumab

  • AusPAR: Migalastat

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Migalastat

  • AusPAR: Rituximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Carbetocin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Carbetocin

  • AusPAR: Ocrelizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ocrelizumab

  • AusPAR: Nivolumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nivolumab

  • AusPAR: Pembrolizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pembrolizumab (rch)

  • AusPAR: Sarilumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sarilumab (rch)

  • AusPAR: Bosentan

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Bosentan

  • AusPAR: Sebelipase alfa

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sebelipase alfa

  • AusPAR: Adalimumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab

  • AusPAR: Cladribine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cladribine

  • AusPAR: Dupilumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dupilumab